大腸内視鏡検査を受けた患者におけるNPF-08の研究

基本情報

NCT ID

NCT03794310

ステータス

完了

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

632

治験依頼者名

Nihon Pharmaceutical Co., Ltd

概要

To study non-inferiority of intestinal cleansing effect in both NPF-08 1-day treatment group and NPF-08 2-day split dose group to the cleansing effect in Moviprep® 1-day treatment group, for the subjects who will receive endoscopy large bowel. If the non-inferiority will be validated, superiority of intestinal cleansing effect in both groups of NPF-08 will be studied. Furthermore, for the assessment of safety of NPF-08, the adverse events and adverse drug reactions observed after the administration to post-examination period will be studied, compared to those at Moviprep® 1-day treatment group.

対象疾患

介入

依頼者（Sponsor）

実施施設 (13)